Real Heart
The answer first
Does Real Heart beat the market?
No, Real Heart has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 17% of Nordic stocks
- Quality48
- Value10
- Trend41
No. 141 of 195 in healthcare
Max for seven days
Follow Real Heart with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Real Heart
Your first answer is free, no account needed.
Do you own Real Heart, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Real Heart and a few more. Free, no card.
Super Stock+46.4%In short
- Real Heart has risen 9.1% over the past year, including dividends.
- Overall, Real Heart ranks better than 17% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 96.1%. The price is 99.1% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 17% of Nordic stocks.
No. 141 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 133 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.04
- Asset turnoverSales divided by everything the company owns0.00
- Return on equityProfit divided by equity−43.8%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 136 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.4
- P/SPrice divided by sales900.6
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 85 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−16.6%
- 6 months−11.6%
- 9 months+11.4%
- 12 months+9.1%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Real Heart
Real Heart is a company in healthcare, listed on Nasdaq Stockholm. By market value, Real Heart is number 80 of 137 companies in healthcare on Nasdaq Stockholm. Real Heart has not paid a dividend in the past twelve months. Of the three measures in the ranking, Real Heart is strongest on quality, better than 48% of Nordic stocks. The share trades in SEK. It has around 18 employees.
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.


See the full analysis of Real Heart.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card